Optimal Lung Cancer Pathway Research Articles

A two-cycle audit of the radiology components of the National Optimal Lung Cancer Pathway at St George’s Hospital

A two-cycle audit of the radiology components of the National Optimal Lung Cancer Pathway at St George’s Hospital

Changes in lung cancer staging and emergency presentations during the first year of the COVID-19 pandemic.

Aim: This study retrospectively analyses the impact of the 1st year of the COVID-19 pandemic on route of presentation and staging in lung cancer compared to the 2years before and after implementation of the Leicester Optimal Lung Cancer Pathway (LOLCP) in Leicester, United Kingdom. Method: Electronic databases and hospital records were used to identify all patients diagnosed with lung cancer in 2018 (pre-LOLCP), 2019 (post-LOLCP), and March 2020-2021 (post-COVID-19 lockdown). Information regarding patient characteristics, performance status, stage, and route of diagnosis was documented and analysed. Emergency presentation was defined as diagnosis of new lung cancer being made after unscheduled attendance to urgent or emergency care facility. Results: Following implementation of the LOLCP pathway, there was a significant decrease in emergency presentations from 26.8 to 19.6% (p = 0.002) with a stage shift from 33.9% early stage disease to 40.3%. These improved outcomes were annulled during the COVID-19 pandemic, with emergency presentations increasing to 38.9% (p < 0.001) and a reduction in early-stage lung cancer diagnoses to 31.5%. There was a 61% decline in 2week wait referrals but no significant decline in the LOLCP direct-to-CT referrals. Conclusion: We have demonstrated a significant increase in late-stage lung cancer diagnoses and emergency presentations during the first year of the COVID-19 pandemic. The causes for these changes are likely to be multifactorial. The long-term effect on lung cancer mortality remains to be seen and is an important focus of future study.

5 - Impact of the New Optimal Lung Cancer Pathway (NOLCP) at Cambridge University Hospitals (CUH) NHS Trust

5 - Impact of the New Optimal Lung Cancer Pathway (NOLCP) at Cambridge University Hospitals (CUH) NHS Trust

Impact of radiographer immediate reporting of X-rays of the chest from general practice on the lung cancer pathway (radioX): a randomised controlled trial

The National Optimal Lung Cancer Pathway recommends rapid progression from abnormal chest X-rays (CXRs) to CT. The impact of the more rapid reporting on the whole pathway is unknown. The...

EP01.06-002 Impact of Immediate AI Enabled Patient Triage to Chest CT on the Lung Cancer Pathway: LungIMPACT

In England, 30% of patients die within 90 days of diagnosis and late diagnosis is strongly implicated in comparatively poor survival shown by the International Cancer Benchmarking Partnership. UK guidance recommends the chest radiograph (CXR) for initial investigation of certain red-flag symptoms but CXRs are done for many indications and may pick up lung cancer as an incidental finding. Thus, the National Optimal Lung Cancer Pathway (NOLCP) was developed to address, amongst other issues, a rapid process from progress from abnormal CXR to CT and clinic.

95 - Incidence and outcomes of malignant disease, other than lung cancer, diagnosed via the direct to chest CT pathway (DtCCTP) of the National Optimal Lung Cancer Pathway (NOLCP)

95 - Incidence and outcomes of malignant disease, other than lung cancer, diagnosed via the direct to chest CT pathway (DtCCTP) of the National Optimal Lung Cancer Pathway (NOLCP)

P28.03 An Autoethnographic Study Exploring the Role of the Lung Cancer Nurse Specialist in the National Optimal Lung Cancer Pathway

Background: The National Optimal Lung Cancer Pathway (NOLCP) is a pathway hospitals in the UK are expected to follow which advocates a standardised care pathway. The pathway is aimed at improving lung cancer care to enable time to treatment within 49 days. The Lung Cancer Nurse Specialist is a core member of the Multidisciplinary Team providing expert knowledge, specialist assessment and advanced communication. They also act as an advocate for patients on the NOLCP. The aim of study was to explore the role of Lung Cancer Nurse Specialist in the NOLCP and the Lung Cancer Specialist Nurse's experience of the “meet the Lung CNS “ aspect of the NOLCP. An autoethnographic study of 16 practicing Lung Cancer Nurse Specialist’s from different centres across the country who reflected on the first meeting with two patients on the NOLCP. Written reflections were subjected to thematic analysis and Gibbs reflective model was used to complete the reflections. Four key themes were identified: 1. Co-ordination of complex care. This is delivering care in accordance with the NOLCP, avoiding delays and ensuring right care, right time in the right place. 2. Relationship building and advanced communication. Utilising specialised knowledge along woth advanced listening and communication skills. Being accessible and providing accurate information and advice 3. Specialist patient assessment and management. This involves the undertaking of specialist holistic assessments to support the treatment and management of lung cancer and its symptoms. 4. Support and management of emotions and expectations. Providing emotional support and management of unrealistic expectations for patients and relatives, as well as themselves and the wider healthcare community These four themes were underpinned by a fifth cross-cutting theme which was effective utilisation of resources. Lung Cancer Nurse Specilaists are pivotal in the delivery of high quality lung cancer care. Through the provision of specialist and expert nursing care, Lung Cancer Nurse Specialists co-ordinate complex care, undertake holistic patient assessment and support and management expectations. This is achieved through successful relationship building and advanced communication skills and appropriate and effective utilisation of resources. Recommendations Clarification of the Lung Cancer Nurse Specialist role is required both locally & nationally. Implementation of the NOLCP will add increased demand on Lung Cancer Nurse Specialist services which are already under-resourced. Adequate provision must be made to meet this requirement.

18 - Optimal lung cancer pathway implementation in a tertiary care centre and its impact on reducing emergency presentations

18 - Optimal lung cancer pathway implementation in a tertiary care centre and its impact on reducing emergency presentations

54 - The impact of anticoagulation and antiplatelet drugs on the National Optimal Lung Cancer Pathway

54 - The impact of anticoagulation and antiplatelet drugs on the National Optimal Lung Cancer Pathway

53 - A patients’ satisfaction survey on speed of the Leicester optimal lung cancer pathway

53 - A patients’ satisfaction survey on speed of the Leicester optimal lung cancer pathway

177 - Introduction of Lung Cancer Patient Navigator at North Middlesex University Hospital (NMUH): how does it influence performance in meeting National Optimal Lung Cancer Pathway Times?

177 - Introduction of Lung Cancer Patient Navigator at North Middlesex University Hospital (NMUH): how does it influence performance in meeting National Optimal Lung Cancer Pathway Times?

172 - An autoethnographic study to explore “meet the Lung CNS” as stated within The National Optimal Lung Cancer Pathway (NOLCP) guidance: recommendations for best practice

172 - An autoethnographic study to explore “meet the Lung CNS” as stated within The National Optimal Lung Cancer Pathway (NOLCP) guidance: recommendations for best practice

Improving Lung Cancer Pathway - The Significance of Marginal Gains

Background: The National Optimal Lung Cancer Pathway (NOLCP) guidelines was published recently. The aim of NOLCP is to encourage local services to review their pathways.

P1.07-11 An Evaluation of the Patient’s Experience and Expectations During the Implementation of NHS England, National Optimal Lung Cancer Pathway

P1.07-11 An Evaluation of the Patient’s Experience and Expectations During the Implementation of NHS England, National Optimal Lung Cancer Pathway

National Optimal Lung Cancer Pathway implementation: can pathologists comply with turnaround times?

National Optimal Lung Cancer Pathway implementation: can pathologists comply with turnaround times?

Implementation of National Optimal Lung Cancer Pathway: an early experience

Implementation of National Optimal Lung Cancer Pathway: an early experience

National Optimal Lung Cancer Pathway: implementation of a ‘straight to CT’ pathway at NUH

National Optimal Lung Cancer Pathway: implementation of a ‘straight to CT’ pathway at NUH

The value of the lung cancer nurse specialist in the development and implimentation of the local optimal lung cancer pathway

The value of the lung cancer nurse specialist in the development and implimentation of the local optimal lung cancer pathway

Implementation of the National Optimal Lung Cancer Pathway: the Nottingham experience

Implementation of the National Optimal Lung Cancer Pathway: the Nottingham experience

Achieving the National Optimal Lung Cancer Pathway: the role of the biomedical scientist

Achieving the National Optimal Lung Cancer Pathway: the role of the biomedical scientist